# Clozapine-Induced Toxic Megacolon: A Rare but Serious Complication

**Authors:** Erick A Boldt, Yatin Srinivash Ramesh Babu, Rohan V Rajan, Jeffrey Joppen, Evan Reilly, Sachin Singh

PMC · DOI: 10.7759/cureus.94228 · Cureus · 2025-10-09

## TL;DR

This paper reports a fatal case of toxic megacolon caused by clozapine, emphasizing the need for awareness of this rare but serious side effect.

## Contribution

The paper highlights toxic megacolon as an under-recognized and life-threatening complication of clozapine therapy.

## Key findings

- A 29-year-old patient on clozapine developed toxic megacolon leading to multiple organ failure and death.
- The case underscores the importance of early recognition and management of gastrointestinal complications in clozapine users.
- Toxic megacolon is a rare but severe adverse effect that can rapidly progress to life-threatening conditions.

## Abstract

Clozapine is a highly effective antipsychotic medication used for treatment-resistant schizophrenia and schizoaffective disorder, with its use most notably associated with the risk of agranulocytosis. As a result, patients on clozapine are routinely screened and monitored for agranulocytosis, but toxic megacolon--a rare and life-threatening gastrointestinal complication--remains an under-recognized adverse effect.

We report the case of a 29-year-old female psychiatric hospital resident with a history of schizoaffective disorder who developed a toxic megacolon while on clozapine therapy. The patient presented with 24 hours of delirium, altered mental status, and a distended, painful abdomen. Despite stabilization efforts, her condition rapidly deteriorated. Emergent decompressive laparotomy revealed a massively dilated colon with solid stool. Postoperatively, she developed abdominal compartment syndrome and underwent a total colectomy for colonic necrosis. Multiple organ failures, including small bowel obstruction, pulmonary emboli, and septic shock, further complicated her clinical course. Despite maximal ICU-level care, she did not survive her condition. This case highlights the need for heightened vigilance and prompt intervention in managing gastrointestinal complications associated with clozapine therapy.

## Linked entities

- **Chemicals:** clozapine (PubChem CID 135398737)
- **Diseases:** schizophrenia (MONDO:0005090), schizoaffective disorder (MONDO:0005487), agranulocytosis (MONDO:0001609), toxic megacolon (MONDO:0002105)

## Full-text entities

- **Diseases:** compartment syndrome (MESH:D003161), delirium (MESH:D003693), Toxic Megacolon (MESH:D008532), colonic necrosis (MESH:D003108), small bowel obstruction (MESH:D007409), schizophrenia (MESH:D012559), gastrointestinal complication (MESH:D005767), agranulocytosis (MESH:D000380), schizoaffective disorder (MESH:D011618), organ failures (MESH:D009102), pulmonary emboli (MESH:D020766), septic shock (MESH:D012772)
- **Chemicals:** Clozapine (MESH:D003024)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12596182/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12596182/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12596182/full.md

---
Source: https://tomesphere.com/paper/PMC12596182